Moderna (MRNA) EV to EBITDA (2018 - 2026)
Moderna's (MRNA) quarterly EV to EBITDA came in at 27.98 in Q2 2026, down 353.06% year-over-year from 11.06 in Q2 2025, and down 159.56% quarter-over-quarter from 10.78 in Q1 2026.
Powered by 
Analysis
Moderna (MRNA) EV to EBITDA (2018 - 2026) Analysis & Trends
Moderna (MRNA) has reported EV to EBITDA for 9 consecutive years, with 27.98 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to EBITDA fell 353.06% year-over-year to 27.98 in Q2 2026; TTM through Jun 2026 was 6.87, a 301.34% decrease from a year earlier, with the FY2025 full-year figure at 1.89, up 17.24% from the prior year.
- EV to EBITDA was 27.98 for Q2 2026 at Moderna, down from 10.78 in the prior quarter.
- Over five years, EV to EBITDA peaked at 4897.65 in Q4 2023 and troughed at 269.47 in Q3 2024.
- A 5-year average of 245.59 and a median of 9.01 in 2026 frame the typical range for EV to EBITDA.
- Across the five-year window, EV to EBITDA soared 12960.03% in 2023 and plunged 1605.96% in 2024, its largest moves.
- Over 5 years, EV to EBITDA stood at 37.5 in 2022, then soared by 12960.03% to 4897.65 in 2023, then tumbled by 100.15% to 7.24 in 2024, then gained by 6.24% to 6.79 in 2025, then plunged by 312.01% to 27.98 in 2026.
- The last three EV to EBITDA figures came in at 27.98 (Q2 2026), 10.78 (Q1 2026), and 6.79 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Moderna | 72.66 Bn | 67.52 Bn | 52.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.98 |
| Mar 31, 2026 | -10.78 |
| Dec 31, 2025 | -6.79 |
| Sep 30, 2025 | -21.52 |
| Jun 30, 2025 | -6.18 |
| Mar 31, 2025 | -4.76 |
| Dec 31, 2024 | -7.24 |
| Sep 30, 2024 | -269.47 |
| Jun 30, 2024 | -27.23 |
| Mar 31, 2024 | -25.51 |
| Dec 31, 2023 | 4,897.65 |
| Sep 30, 2023 | -15.80 |
| Jun 30, 2023 | -20.26 |
| Mar 31, 2023 | -136.75 |
| Dec 31, 2022 | 37.50 |
| Sep 30, 2022 | 32.09 |
| Jun 30, 2022 | 19.66 |
| Mar 31, 2022 | 13.91 |
| Dec 31, 2021 | 16.94 |
| Sep 30, 2021 | 41.30 |
API Access
Moderna EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();